This inventor holds 2 USPTO granted patents. Top assignees: University of Massachusetts, St. Jude Children's Research Hospital. Active years: 2000-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000-2010
Title: Andre J. Van Wijnen: Patents in Nuclear Biology
Introduction
Andre J. Van Wijnen is an inventor associated with Auburn, Massachusetts. His patent work includes methods for analyzing the organization of biological molecules within cell nuclei and technology for delivering agents to the nuclear matrix. He is credited with 2 patents.
Latest Patents
“Quantitative Assessment of Biological Function Based on the Temporal and Spatial Organization of Subnuclear Domains” describes a method for analyzing the distribution of supramolecular complexes in nuclear microenvironments. The approach quantifies organizational features of subnuclear domains and uses factor and discriminant analyses to identify molecules based on their distribution. The invention is intended to support quantitative study of regulatory machinery within nuclear architecture and its relationship to biological control.
“Isolated Nuclear Matrix Targeting Peptide” discloses nuclear matrix targeting peptides designed to deliver therapeutic or diagnostic agents, including transcription-regulatory factors, to a cell’s nuclear matrix.
Career Highlights
Van Wijnen’s listed institutional affiliations include the University of Massachusetts and St. Jude Children’s Research Hospital. His patents reflect research interests at the intersection of nuclear organization, biological regulation, and potential therapeutic delivery.
Collaborations
His listed collaborators include Janet L. Stein and Jane B. Lian, researchers associated with work in bone biology and gene regulation.
Conclusion
Andre J. Van Wijnen’s two patents address ways to study subnuclear organization and target agents to the nuclear matrix, connecting fundamental cell biology with potential diagnostic and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile